AllNewsPhotosVideos
Drug Controller General of India

Drugs Controller General Of India

Drugs controller general of india, Latest News

SII asked to submit approvals from DSMB India & UK to resume vax trial - Hindi News | SII asked to submit approvals from DSMB India & UK to resume vax trial | Latest health News at Lokmattimes.com

Health :SII asked to submit approvals from DSMB India & UK to resume vax trial

New Delhi, Sep 12 The Drug Controller General of India (DCGI) has directed the Serum Institute of India ... ...

DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials - Hindi News | DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials | Latest national News at Lokmattimes.com

National :DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders. ...

DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials - Hindi News | DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials | Latest national News at Lokmattimes.com

National :DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders. ...

DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine - Hindi News | DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine | Latest national News at Lokmattimes.com

National :DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine

The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubt ...

Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment - Hindi News | Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment | Latest business News at Lokmattimes.com

Business :Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment

Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets. ...

Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment - Hindi News | Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment | Latest health News at Lokmattimes.com

Health :Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment

New Delhi, Aug 6 Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to ... ...

COVID-19: Health Ministry directs DCGI to ensure equitable distribution of 'investigational therapy' drugs nationwide - Hindi News | COVID-19: Health Ministry directs DCGI to ensure equitable distribution of 'investigational therapy' drugs nationwide | Latest national News at Lokmattimes.com

National :COVID-19: Health Ministry directs DCGI to ensure equitable distribution of 'investigational therapy' drugs nationwide

The Union Health and Family Welfare Ministry has directed the Drugs Controller General of India (DCGI) to ensure equitable distribution of drugs across the country included as part of "investigational therapies" in clinical management protocol for CO ...

COVID-19: Health ministry decides not to put Itolizumab in national treatment protocol - Hindi News | COVID-19: Health ministry decides not to put Itolizumab in national treatment protocol | Latest national News at Lokmattimes.com

National :COVID-19: Health ministry decides not to put Itolizumab in national treatment protocol

Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe COVID-19 patients, the Union Health Ministry has decided not to include the drug in the national treatment ...